Aptamer-based Biosensor Developed to Monitor MUC1 Released by Prostate Cancer Cells

被引:27
|
作者
Karpik, Agnieszka E. [1 ]
Crulhas, Bruno P. [2 ]
Rodrigues, Carolina B. [2 ]
Castro, Gustavo R. [2 ]
Pedrosa, Valber A. [2 ]
机构
[1] Inst Mat Sci & Engn, Fac Mech Engn, Lodz, Poland
[2] UNESP, Dept Chem & Biochem, Inst Biosci, Botucatu, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Electrochemical detection; protein monitoring; cancer; biomarkers; aptamers; ELECTROCHEMICAL DETECTION; ENZYME-IMMUNOASSAY; PANCREATIC-CANCER; LIGHT-SCATTERING; TUMOR; ONCOPROTEIN; APTASENSOR; EXPRESSION; ANTIGEN; TRANSCRIPTION;
D O I
10.1002/elan.201700318
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Electrochemical aptasensors can detect cancer biomarkers such as mucin 1 (MUC1) to provide point-of-care diagnosis that is low-cost, specific and sensitive. Herein, a DNA hairpin containing MUC1 aptamer was thiolated, conjugated with methylene blue (MB) redox tag, and immobilized on a gold electrode by self-assembly. The fabrication process was characterized by scanning electron microscopy, X-ray spectroscopy analysis and electrochemistry techniques. The results evidenced a stable and sensitivity sensor presenting wide linear detection range (0.65-110 ng/mL). Therefore, it was able to precisely detect MUC1 production patterns in normal (RWPE-1) and prostate cancer cells (LNCaP and PC3). The biosensor has ability to detect MUC1 in complex samples being an efficient and useful platform for cancer diagnosing in early stages and for physiological applications such as cancer treatment monitoring.
引用
收藏
页码:2246 / 2253
页数:8
相关论文
共 50 条
  • [21] Recent advances in aptamer-based sensors for breast cancer diagnosis: special cases for nanomaterial-based VEGF, HER2, and MUC1 aptasensors
    Samet Şahin
    Mustafa Oguzhan Caglayan
    Zafer Üstündağ
    Microchimica Acta, 2020, 187
  • [22] Targeting lung cancer cells with MUC1 aptamer-functionalized PLA-PEG nanocarriers
    Shahrad, Shima
    Rajabi, Mohammad
    Javadi, Hamidreza
    Zarchi, Ali Akbar Karimi
    Darvishi, Mohammad Hasan
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [23] Targeting lung cancer cells with MUC1 aptamer-functionalized PLA-PEG nanocarriers
    Shima Shahrad
    Mohammad Rajabi
    Hamidreza Javadi
    Ali Akbar Karimi Zarchi
    Mohammad Hasan Darvishi
    Scientific Reports, 12
  • [24] MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells
    Hanafi-Bojd, Mohammad Yahya
    Kalat, Seyedeh Alia Moosavian
    Taghdisi, Seyed Mohammad
    Ansari, Legha
    Abnous, Khalil
    Malaekeh-Nikouei, Bizhan
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2018, 44 (01) : 13 - 18
  • [25] Amplification of MUC1 in prostate cancer metastasis and CRPC development
    Wong, Nicholas
    Major, Pierre
    Kapoor, Anil
    Wei, Fengxiang
    Yan, Judy
    Aziz, Tariq
    Zheng, Mingxing
    Jayasekera, Dulitha
    Cutz, Jean-Claude
    Chow, Mathilda Jing
    Tang, Damu
    ONCOTARGET, 2016, 7 (50) : 83115 - 83133
  • [26] MUC1 is a promising therapeutic target for prostate cancer therapy
    Li, Y.
    Cozzi, P. J.
    CURRENT CANCER DRUG TARGETS, 2007, 7 (03) : 259 - 271
  • [27] MUC1 Aptamer Based Near Infrared Fluorescence Probes for Tumor Diagnosis
    Zhao, Juan
    Ma, Yuxiang
    Cui, Sisi
    Cao, Jie
    Achelifu, Samuel
    Gu, Yueqing
    REPORTERS, MARKERS, DYES, NANOPARTICLES, AND MOLECULAR PROBES FOR BIOMEDICAL APPLICATIONS V, 2013, 8596
  • [28] MUC1 as a marker on cancer stem and progenitor cells
    Engelmann, Katja
    Shen, Hongmei
    Finn, Olivera J.
    CANCER RESEARCH, 2006, 66 (08)
  • [29] Reduced Graphene Oxide Decorated with AuNPs as a New Aptamer-Based Biosensor for the Detection of Androgen Receptor from Prostate Cells
    Crulhas, Bruno P.
    Basso, Caroline R.
    Parra, Joao P. R. L. L.
    Castro, Gustavo R.
    Pedrosa, Valber A.
    JOURNAL OF SENSORS, 2019, 2019
  • [30] The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer
    Curry, Jennifer M.
    Thompson, Kyle J.
    Rao, Shanti G.
    Besmer, Dahlia M.
    Murphy, Andrea M.
    Grdzelishvili, Valery Z.
    Ahrens, William A.
    McKillop, Iain H.
    Sindram, David
    Iannitti, David A.
    Martinie, John B.
    Mukherjee, Pinku
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (07) : 713 - 722